Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Bilimetrix s.r.l. logo — We dream of a world free from kernicterus, a preventable dis...

Bilimetrix s.r.l.

We dream of a world free from kernicterus, a preventable disabling condition, allowing newborns to enjoy a healthy life.

Founded 2012 Italy Italy 3 employees Seed Total: $50.00K Biotechnology, Health Care

General Information

Company Name Bilimetrix s.r.l.
Founded Year 2012
Location Italy Italy
Employees 3
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Bilimetrix s.r.l.. To contact Bilimetrix s.r.l., visit bilimetrix.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Bilimetrix s.r.l.

Bilimetrix s.r.l. is a R&D Biomed company founded in 2012, based in Italy, with a clear vision: "We dream of a world free from kernicterus, a preventable disabling condition, allowing newborns to enjoy a healthy life." The company has developed the innovative Bilistick® System, an in vitro Point of Care (POC) system for early diagnosis of hyperbilirubinemia. It is the only in vitro rapid diagnostic for measuring the level of bilirubin in newborns' blood. The mission of Bilimetrix is to provide key stakeholders with low-cost, effective solutions to monitor neonatal jaundice and prevent kernicterus. The company's last investment was a €50.00K Seed Round investment on 02 January 2016, with EASME - EU Executive Agency for SMEs as the investor. The Bilistick® serves a critical need in developing countries for guiding treatment decisions of jaundiced newborns where laboratory resources for rapid bilirubin assays are often unavailable. Furthermore, it benefits hospitals and doctors in western countries, providing them with useful tools for appropriate neonatal jaundice management. In summary, Bilimetrix s.r.l. stands at the forefront of Biotechnology and Health Care, addressing a crucial global health issue with its innovative technology and impactful vision.

Taxonomy: In Vitro Diagnostics (IVD), Lateral Flow, Neonatal Jaundice, Neonatology, Pediatrics, Rapid Diagnostic, Point of Care (POC), Healthcare Innovation, Global Health, Preventative Medicine, Biomedical Research, Clinical Diagnostics, Startup

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €50.00K 1
EASME - EU Executive Agency for SMEs
02 Jan 2016

Bilimetrix s.r.l. Alternatives & Competitors

View All Alternatives
Bilimetrix s.r.l. vs
HemoSonics
HemoSonics United States

Breaking New Ground in Bleeding Management with POC Viscoelastic Testing

Venture round
110 employees
Biotechnology, Health Care
Bilimetrix s.r.l. vs
TB Biosciences
TB Biosciences

Pioneering a new era in tuberculosis diagnostics with a rapid, user-friendly test replacing century-...

Series A
Biotechnology, Health Care
Bilimetrix s.r.l. vs
OVVI Diagnostics Srl
OVVI Diagnostics Srl Belgium

The first Point-of-Care testing system exclusively focused on Women’s health.

1 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bilimetrix s.r.l.

We dream of a world free from kernicterus, a preventable disabling condition, allowing newborns to enjoy a healthy life.
Bilimetrix s.r.l. was founded in 2012.
Bilimetrix s.r.l. is headquartered in Italy.
Bilimetrix s.r.l. operates in Biotechnology and Health Care. Its work centres on In Vitro Diagnostics (IVD), Lateral Flow, Neonatal Jaundice and Neonatology.
Bilimetrix s.r.l. has approximately 3 employees.
Bilimetrix s.r.l. has completed 1 funding round, raising a total of $50.00K. The latest funding stage is Seed.
Top alternatives and competitors to Bilimetrix s.r.l. include HemoSonics, TB Biosciences, OVVI Diagnostics Srl, NanoDx, Inc., Biosensia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bilimetrix s.r.l. and HemoSonics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bilimetrix s.r.l., https://bouncewatch.com/company/bilimetrix-srl, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes